Retinavab (Retinacor)
Product detail for Retinavab, INN: retinavab. Therapeutic area: Ophthalmology. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-016
INN
retinavab
Therapeutic Area
Ophthalmology
Status
Pending
Owner
Tomoko Ikeda
Created
2022-12-03
Last Updated
2023-07-26
Markets
3
Presentations
| Form | Strength | Route |
|---|---|---|
| Oral solution | 5 mg | Topical |
| Transdermal patch | 200 mg | Intravenous |
| Transdermal patch | 1 mg/mL | Intravenous |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-006 | Dupitumacon | dupitumacon | 96608-78-2 | biologic | Active |
| SUB-046 | Cyclodextrin | cyclodextrin | 85528-98-1 | small-molecule | Pending |
Applications (3)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| TITCK-2024-0016 | Taiwan | sBLA | Pending | Aisha Okonkwo | 2023-03-10 |
| HC-2024-0046 | Taiwan | NDS | Approved | Carlos Mendez | 2023-10-13 |
| TITCK-2024-0076 | Taiwan | MAA | Pending | Carlos Mendez | 2024-05-18 |